
Pardes Biosciences
We break viruses
About
We make oral drugs to treat and prevent viral infections - like COVID-19.
Topics
- Location
- San Francisco, CA, United States
- Team size
- 2 employees
- YC batch
- Summer 2020
- Status
- Public
- Stage
- Early stage

We break viruses
We make oral drugs to treat and prevent viral infections - like COVID-19.

What they do:
Targeting Cancer with Click Chemistry
Quick facts:
HQ: San Francisco, CA, United States

What they do:
Using CRISPR to find treatments for cancer and inflammation
Quick facts:
HQ: San Francisco, CA, United States

What they do:
Adventris makes cancer vaccines
Quick facts:
HQ: Baltimore, MD, United States

What they do:
Deliver genes to any cell with AI
Quick facts:
HQ: London, United Kingdom

What they do:
Artificial intelligence for drug discovery.
Quick facts:
HQ: San Francisco, CA, United States
Funding:
$19.8M · Equity · Mar 2026

What they do:
Using the immune system to cure disease
Quick facts:
HQ: San Francisco, CA, United States
We break viruses
San Francisco, CA, United States
2 employees, according to the company profile.
There are no funding rounds for Pardes Biosciences in our data.
Similar startups: Shasqi, Algen Biotechnologies, and Adventris Pharmaceuticals.